Brief: Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property
03/03/2025 06:04
March 3 (Reuters) - QIAGEN NV QIA.DE: TAKES LEGAL ACTION TO DEFEND QUANTIFERON INTELLECTUAL PROPERTY AND PROTECT INNOVATIONS IN LATENT TUBERCULOSIS TESTING COMPLAINT, FILED IN LOCAL DIVISION OF COURT OF FIRST INSTANCE OF UNIFIED PATENT COURT (UPC) IN DUESSELDORF, GERMANY, CONCERNS EUROPEAN PATENT EP 2 276 883 B2 FILES LAWSUIT AGAINST BIOMÉRIEUX WITH GERMAN UNIFIED PATENT COURT TO PROTECT KEY INNOVATIONS IN ITS QUANTIFERON TECHNOLOGY Source text: ID:nBw2DVq5da Further company coverage: QIA.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))